Market Research Logo

Perrigo Co Plc (PRGO) - Financial and Strategic SWOT Analysis Review

Perrigo Co Plc (PRGO) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Perrigo Co plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutical ingredients (APIs) and infant formulas. The company’s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream. It markets products through wholesalers, retail drug, supermarket and mass merchandise chains and direct sales representatives. The company has operations in North America, Europe, Australia and other countries including Israel and China. Perrigo is headquartered in Dublin, Ireland.

Perrigo Co Plc Key Recent Developments

May 09,2019 Perrigo unveils self-care transformation plan, 2019 guidance and long-term growth targets at investor day
May 08,2019 Perrigo Company reports first quarter 2019 financial results, begins consumer self-care transformation
Apr 26,2019 Perrigo receives $843 million tax bill from US Internal Revenue Service
Apr 02,2019 Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Perrigo Co Plc - Key Facts
Perrigo Co Plc - Key Employees
Perrigo Co Plc - Key Employee Biographies
Perrigo Co Plc - Major Products and Services
Perrigo Co Plc - History
Perrigo Co Plc - Company Statement
Perrigo Co Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Perrigo Co Plc - Business Description
Business Segment: CHCA Segment
Overview
Performance
Business Segment: CHCI Segment
Overview
Performance
Business Segment: Rx Pharmaceuticals Segment
Overview
Performance
Geographical Segment: All Other Countries
Target Markets
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: The US
Performance
R&D Overview
Perrigo Co Plc - Corporate Strategy
Perrigo Co Plc - SWOT Analysis
SWOT Analysis - Overview
Perrigo Co Plc - Strengths
Perrigo Co Plc - Weaknesses
Perrigo Co Plc - Opportunities
Perrigo Co Plc - Threats
Perrigo Co Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Perrigo Co Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 09, 2019: Perrigo unveils self-care transformation plan, 2019 guidance and long-term growth targets at investor day
May 08, 2019: Perrigo Company reports first quarter 2019 financial results, begins consumer self-care transformation
Apr 26, 2019: Perrigo receives $843 million tax bill from US Internal Revenue Service
Apr 02, 2019: Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam
Mar 20, 2019: Perrigo Company names Ray Silcock as Chief Financial Officer
Feb 27, 2019: Perrigo Company reports fourth quarter and full-year 2018 financial results
Feb 25, 2019: Perrigo receives leave to judicially review Irish revenue tax assessment
Jan 14, 2019: Perrigo Company names James Dillard to role of chief scientific officer
Dec 21, 2018: Irish authorities demand €1.6bn in back tax from Perrigo
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Perrigo Co Plc, Key Facts
Perrigo Co Plc, Key Employees
Perrigo Co Plc, Key Employee Biographies
Perrigo Co Plc, Major Products and Services
Perrigo Co Plc, History
Perrigo Co Plc, Subsidiaries
Perrigo Co Plc, Key Competitors
Perrigo Co Plc, Ratios based on current share price
Perrigo Co Plc, Annual Ratios
Perrigo Co Plc, Annual Ratios (Cont...1)
Perrigo Co Plc, Annual Ratios (Cont...2)
Perrigo Co Plc, Interim Ratios
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Perrigo Co Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Perrigo Co Plc, Performance Chart (2014 - 2018)
Perrigo Co Plc, Ratio Charts
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report